Pulmonary veno-occlusive disease: a rare cause of pulmonary hypertension in systemic sclerosis. Case presentation and review of the literature

1. SIMONNEAU G, GATZOULIS MA, ADATIA I, CELERMAJER D, DENTON C, GHOFRANI A, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013;62:D34–41.10.1016/j.jacc.2013.10.02924355639Search in Google Scholar

2. The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Guidelines for the diagnosis and treatment of pulmonary hypertension. European Heart Journal 2009; 30:2493–2537.10.1093/eurheartj/ehp29719713419Search in Google Scholar

3. MONTANI D, PRICE LC, DORFMULLER P, ACHOUH L, JAÏS X, YAÏCI A, et al. Pulmonary veno-occlusive disease. Eur Respir J 2009; 33: 189–200.10.1183/09031936.0009060819118230Search in Google Scholar

4. MORASSUT PA, WALLEY VM, SMITH CD. Pulmonary veno-occlusive disease and the CREST variant of scleroderma. Can J Cardiol. 1992;8(10):1055-1058.Search in Google Scholar

5. ZHANG L, VISSCHER D, RIHAL C, AUBRY MC. Pulmonary veno-occlusive disease as a primary cause of pulmonary hypertension in a patient with mixed connective tissue disease. Rheumatol Int 2007; 27: 1163–1165.10.1007/s00296-007-0362-117520258Search in Google Scholar

6. HOURSEAU M, CAPRON F, NUNES H, GODMER P, MARTIN A, KAMBOUCHNER M. Pulmonary veno-occlusive disease in a patient with HIV infection. A case report with autopsy findings. Ann Pathol. 2002;22(6):472-475.Search in Google Scholar

7. WILLIAMS LM, FUSSELL S, VEITH RW, NELSON S, MASON CM. Pulmonary veno-occlusive disease in an adult following bone marrow transplantation. Case report and review of the literature. Chest 1996; 109: 1388–1391.10.1378/chest.109.5.13888625695Search in Google Scholar

8. SEGUCHI M, HIRABAYASHI N, FUJII Y, et al. Pulmonary hypertension associated with pulmonary occlusive vasculopathy after allogeneic bone marrow transplantation. Transplantation 2000; 69: 177–179.10.1097/00007890-200001150-0003010653399Search in Google Scholar

9. NUNES H, HUMBERT M, CAPRON F, et al. Pulmonary hypertension associated with sarcoidosis: mechanisms, hemodynamics and prognosis. Thorax 2006; 61: 68–74. 3110.1136/thx.2005.042838208070316227329Search in Google Scholar

10. FARTOUKH M, HUMBERT M, CAPRON F, et al. Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med 2000; 161: 216–223.10.1164/ajrccm.161.1.980702410619823Search in Google Scholar

11. KHANNA D. Diagnosis and treatment of systemic and localized scleroderma. Expert Rev. Dermatol. 2011; 6(3):287–302.Search in Google Scholar

12. CHAISSON NF, HASSOUN PM. Systemic Sclerosis-Associated Pulmonary Arterial Hypertension. CHEST 2013; 144(4): 1346–1356.10.1378/chest.12-2396378792024081346Search in Google Scholar

13. LAMBOVA S. Cardiac manifestations in systemic sclerosis. World J Cardiol 2014 26; 6(9): 993-1005.10.4330/wjc.v6.i9.993417680825276300Search in Google Scholar

14. KHANNA D, GLADUE H, CHANNICK R, CHUNG L, DISTLER O, FURST DE, et al. Recommendations for Screening and Detection of Connective-Tissue Disease Associated Pulmonary Arterial Hypertension. Arthritis Rheum. 2013; 65(12): 3194-201.10.1002/art.38172Search in Google Scholar

15. MONTANI D, O’CALLAGHAN DS, SAVALE L, JAÏS X, YAÏCI A, MAITRE S, et al. Pulmonary veno-occlusive disease: Recent progress and current challenges. Respiratory Medicine. 2010; 104:S23eS32.10.1016/j.rmed.2010.03.014Search in Google Scholar

16. HORA J. Zur Histologie der klinischen “primaren Pulmonalsklerose”. Frankfurt Z Pathol. 1934; 47:100-08.Search in Google Scholar

17. RUNO JR, VNENCAK-JONES CL, PRINCE M, et al. Pulmonary venoocclusive disease caused by an inherited mutation in bone morphogenetic protein receptor II. Am J Respir Crit Care Med 2003; 167(6):889e94.10.1164/rccm.200208-861OCSearch in Google Scholar

18. GAGNADOUX F, CAPRON F, LEBEAU B. Pulmonary veno-occlusive disease after neoadjuvant mitomycin chemotherapy and surgery for lung carcinoma. Lung Cancer 2002; 36(2):213e5.10.1016/S0169-5002(01)00479-2Search in Google Scholar

19. JOSELSON R, WARNOCK M. Pulmonary veno-occlusive disease after chemotherapy. Hum Pathol. 1983; 14(1):88-91.10.1016/S0046-8177(83)80052-5Search in Google Scholar

20. LOMBARD CM, CHURG A, WINOKUR S. Pulmonary veno-occlusive disease following therapy for malignant neoplasms. Chest. 1987; 92(5):871-876.10.1378/chest.92.5.8713665603Search in Google Scholar

21. MONTANI D, ACHOUH L, DORFMULLER P, et al. Pulmonary venoocclusive disease: Clinical, functional, radiologic, hemodynamic characteristics and outcome of 24 cases confirmed by histology. Medicine (Baltimore) 2008; 87: 220–233.10.1097/MD.0b013e31818193bb18626305Search in Google Scholar

22. KRAMER MR, ESTENNE M, BERKMAN N, ANTOINE M, DE FRANCQUEN P, LIPSKI A, et al. Radiation-induced pulmonary veno-occlusive disease. Chest. 1993; 104(4):1282-1284.10.1378/chest.104.4.12828404211Search in Google Scholar

23. JOHNSON SR, PATSIOS D, HWANG DM, GRANTON JT. Pulmonary veno-occlusive disease and scleroderma associated pulmonary hypertension. J Rheumatol 2006; 33:2347–2350.Search in Google Scholar

24. LANTUEJOUL S, SHEPPARD MN, CORRIN B, BURKE MM, NICHOLSON AG. Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis: a clinicopathologic study of 35 cases. Am J Surg Pathol 2006; 30: 850–857.10.1097/01.pas.0000209834.69972.e516819327Search in Google Scholar

25. DORFMULLER P, HUMBERT M, PERROS F, et al. Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Hum Pathol 2007; 38: 893–902.10.1016/j.humpath.2006.11.02217376507Search in Google Scholar

26. NICOD P, MOSER KM. Primary pulmonary hypertension. The risk and benefit of lung biopsy. Circulation.1989; 80(5): 1486-1488.10.1161/01.CIR.80.5.14862805280Search in Google Scholar

27. PALMER SM, ROBINSON LJ, WANG A, GOSSAGE JR, BASHORE T, TAPSON VF. Massive pulmonary oedema and death after prostacyclin infusion in a patient with pulmonary venoocclusive disease. Chest 1998; 113: 237–240.10.1378/chest.113.1.2379440597Search in Google Scholar

28. CREAGH-BROWN BC, NICHOLSON AG, SHOWKATHALI R, GIBBS JS, HOWARD LS. Pulmonary veno-occlusive disease presenting with recurrent pulmonary oedema and the use of nitric oxide to predict response to sildenafil. Thorax 2008; 63: 933–934.10.1136/thx.2007.08883118820120Search in Google Scholar

29. GUPTA R. Pulmonary function test as screening test for pulmonary artery hypertension in scleroderma patients. Rheumatology. 2004; 43(10): 1315.10.1093/rheumatology/keh31615448223Search in Google Scholar

30. RABILLER A, JAIS X, HAMID A, et al. Occult alveolar haemorrhage in pulmonary veno-occlusive disease. Eur Respir J 2006; 27: 108–113.10.1183/09031936.06.0005410516387942Search in Google Scholar

31. GŰNTHER S, JAĎS X, MAITRE S, BÉREZNÉ A, DORFMŰLLER, SEFERIAN A, et al. Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension. Arthritis Rheum. 2012; 64(9):2995–3005.10.1002/art.3450122549387Search in Google Scholar

32. MEYER KC, RAGHU G, BAUGHMAN RP, BROWN KK, COSTABEL U, DU BOIS RM, et al. An official american thoracic society clinical practice guideline: The clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med 185(9):1004–1014.10.1164/rccm.201202-0320ST22550210Search in Google Scholar

33. D. MONTANI, X. JAÏS, P. DORFMULLER, G. SIMONNEAU, O. SITBON, M. HUMBERT. Goal-oriented therapy in pulmonary veno-occlusive disease: a word of caution. ERJ 2009; 34 (5):1204-1206.10.1183/09031936.0010260919880623Search in Google Scholar